Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Aperio launches new digital pathology system for Tissue Microarray Analysis

Aperio Technologies : 16 July, 2007  (New Product)
Aperio Technologies has launched TMALab II which is a web-based digital pathology information management system designed specifically for researchers using Tissue Microarrays (TMAs).
TMALab II software enables researchers to analyse and manage hundreds of small tissue samples simultaneously in a meaningful way to facilitate leading research applications such as new Biomarker validation, or discovering and dissecting molecular pathways.

The software is the only web-based product that facilitates multi-user access and server-based image analysis, allowing numerous remote pathologists to collaborate on large TMA projects.

Researchers can easily retrieve all stains for any given core, and all cores for any given specimen. Additionally, the software provides links from any TMA core back to the original H&E slide cut from the corresponding donor block.

'Our first generation TMALab product has been successfully assisting scores of TMA researchers to streamline high-throughput tissue analysis in both the bio-pharma and cancer research arenas for many years,' stated Dirk Soenksen, CEO of Aperio.

'TMALab II enhances the value of our digital pathology solution, sets new standards for ease of integration, and significantly expands data analysis and reporting capabilities for the TMA environment.'

Beta versions of the software have been successfully deployed at the National Cancer Institute in Bethesda, Maryland and the Netherlands Cancer Institute in Amsterdam. TMALab II is currently being used at the National Cancer Institute's Tissue Array Research Program led by Dr Stephen Hewitt.

The initial project involves multiple slides prepared from 32 tissue microarrays. The TMA slides will be scanned using an Aperio ScanScope, annotated by a pathologist accessing the software via the Internet, and scored using quantitative image analysis algorithms. Additional projects have already been initiated using the platform to examine more than 75 stains on a single TMA.

TMALab II is fully integrated into Aperio's patented linear array-based ScanScope slide scanning system and Spectrum digital pathology information management software. For the first time ever, researchers are able to manage digital whole slide-based projects along side TMA projects all within a single unified database containing specimen, digital slide, and TMA core information.

In addition to data management and image retrieval, the software also enables server-based image analysis using any one of Aperio's popular IHC algorithms or any compatible third party algorithms.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo